Skip to content

Multicentre, open-label post-marketing follow-up observational study to evaluate the efficacy/tolerability of the Philips BlueTouch Pain Relief Patch in the daily routine treatment of back pain

Multicentre, open-label post-marketing follow-up observational study to evaluate the efficacy/tolerability of the Philips BlueTouch Pain Relief Patch in the daily routine treatment of back pain - BlueTouch PRP 2013/14

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00005707
Enrollment
1000
Registered
2014-03-25
Start date
2014-01-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Localized unspecific pain of the upper or lower back

Interventions

Group 1: Single arm, multicentre, open-label post-marketing follow-up observational study to evaluate the efficacy/tolerability of the Philips BlueTouch Pain Relief Patch in the daily routine treatmen

Sponsors

Philips Consumer Lifestyle
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient age =18 years Patient is able and willing to understand a written informed consent Patient suffers from back pain Patient is able to comply with the study characteristics and to fulfill its requirements, according to the investigator's evaluation

Exclusion criteria

Exclusion criteria: Patient is currently or was within the previous 4 weeks enrolled in an interventional clinical trial Patient is actually suffering from conditions and illnesses that might interfere with the trial purpose, according to the investigator's evaluation Patient has a history of substance abuse (drug or alcohol) or any other factor (e.g., serious psychiatric condition) that could limit the subject's ability to comply with trial procedures Patient has insufficient knowledge of the German language to understand the Informed Consent Form and/or trial questionnaires Patient is/was involved in the planning and conduct of the trial (applies to either Philips staff, staff participating at the trial site or staff of the logistics CRO) Patient suffers from any condition or illness as listed in the contraindications section of the BlueTouch Pain Relief Patch user manual Patient has used the Philips BlueTouch Pain Relief Patch before

Design outcomes

Primary

MeasureTime frame
Primary outcome on efficacy and tolerability: Queries based on two "verbal rating scales" in the physician's interim documentation (after 1 week of therapy) as well as in the physician's end documentation (after 2 weeks of therapy) compared to the previous non-drug or drug treatments.

Secondary

MeasureTime frame
- Patient-relevant aspects regarding pain-related impairment of activities of daily life - Overall quality of life

Countries

Germany

Contacts

Public ContactGerhard H.H. Müller-Schwefe

Schmerz- und Palliativzentrum Göppingen Deutsche Gessellschaft für Schmerztherapie e.V.

info@mueller-schwefe.de00497161676476

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026